{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T02:20:33Z","timestamp":1772504433897,"version":"3.50.1"},"reference-count":37,"publisher":"Termedia Sp. z.o.o.","issue":"3","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cent Eur J Immunol"],"abstract":"<jats:p>22q11.2 deletion syndrome (MIM: 192430\/188400, ORPHA: 567) is the most common chromosomal microdeletion disorder, caused by a hemizygous microdeletion of 2.5 million base pairs on chromosome 22. There is a known association between 22q11.2 deletion syndrome (22q11.2DS), immunodeficiency and autoimmune diseases. However, the co-occurrence of 22q11.2DS and systemic lupus erythematosus (SLE) has been rarely reported. Here, we describe a case of a female teenager with distal type I 22q11.2DS who presented with alopecia, oral ulcers, fever and thrombocytopenia. Laboratory tests showed positive antinuclear antibodies (ANA) and double-stranded DNA (ds-DNA) antibodies, indicative of SLE. Treatment with prednisone, hydroxychloroquine and azathioprine resulted in improvement. We reviewed the literature on the immunological mechanisms involved in 22q11.2DS. Thymic dysplasia, T-cell lymphopenia, and B-cell abnormalities collectively contribute to the immunodeficiency and autoimmune manifestations observed in individuals with 22q11.2DS. Genetic factors such as 22q11.2DS should be considered in the diagnosis of childhood rheumatic diseases. Our case adds to the limited literature on this co-occurrence.<\/jats:p>","DOI":"10.5114\/ceji.2024.143229","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T05:13:36Z","timestamp":1732857216000},"page":"315-319","source":"Crossref","is-referenced-by-count":2,"title":["Systemic lupus erythematosus in a patient with 22q11.2 deletion syndrome: A case report and review of the literature"],"prefix":"10.5114","volume":"49","author":[{"given":"Chen","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingyang","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juzhen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3061","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"key":"ref-1535000","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3390\/children9081168","article-title":"Deletion syndrome 22q11.2: A systematic Review","volume":"9","author":"Cort\u00e9s-Mart\u00edn J","year":"2022","unstructured":"Cort\u00e9s-Mart\u00edn J, Pe\u00f1uela NL, S\u00e1nchez-Garc\u00eda JC, et al. (2022): Deletion syndrome 22q11.2: A systematic Review. Children 9: 1168.","journal-title":"Children"},{"key":"ref-1535001","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10875-020-00766-x","article-title":"Complement activation in 22q11.2 deletion syndrome","volume":"40","author":"Grinde D","year":"2020","unstructured":"Grinde D, \u00d8verland T, Lima K, et al. (2020): Complement activation in 22q11.2 deletion syndrome. J Clin Immunol 40: 515-523.","journal-title":"J Clin Immunol"},{"key":"ref-1535002","doi-asserted-by":"crossref","first-page":"15071","DOI":"10.1038\/nrdp.2015.71","article-title":"22q11.2 deletion syndrome","volume":"1","author":"Mcdonald-Mcginn DM","year":"2015","unstructured":"Mcdonald-Mcginn DM, Sullivan KE, Marino B, et al. (2015): 22q11.2 deletion syndrome. Nat Rev Dis Primers 1: 15071.","journal-title":"Nat Rev Dis Primers"},{"key":"ref-1535003","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.hfc.2021.07.009","article-title":"Clinical manifestations of 22q11.2 deletion syndrome","volume":"18","author":"Cirillo A","year":"2022","unstructured":"Cirillo A, Lioncino M, Maratea A, et al. (2022): Clinical manifestations of 22q11.2 deletion syndrome. Heart Fail Clin 18: 155-164.","journal-title":"Heart Fail Clin"},{"key":"ref-1535004","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/ajmg.a.38597","article-title":"Variable immune deficiency related to deletion size in chromosome 22q11.2 deletion syndrome","volume":"176","author":"Crowley B","year":"2018","unstructured":"Crowley B, Ruffner M, Mcdonald Mcginn DM, Sullivan KE (2018): Variable immune deficiency related to deletion size in chromosome 22q11.2 deletion syndrome. Am J Med Genet A 176: 2082-2086.","journal-title":"Am J Med Genet A"},{"key":"ref-1535005","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1182\/blood-2003-08-2824","article-title":"T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome","volume":"103","author":"Piliero LM","year":"2004","unstructured":"Piliero LM, Sanford AN, Mcdonald-Mcginn DM, et al. (2004): T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood 103: 1020-1025.","journal-title":"Blood"},{"key":"ref-1535006","doi-asserted-by":"crossref","first-page":"1014249","DOI":"10.3389\/fped.2022.1014249","article-title":"Case report: Effectiveness of sirolimus in treating partial DiGeorge syndrome with autoimmune lymphoproliferative syndrome (ALPS)-like features","volume":"10","author":"Gu H","year":"2022","unstructured":"Gu H, Mou W, Chen Z, et al. (2022): Case report: Effectiveness of sirolimus in treating partial DiGeorge syndrome with autoimmune lymphoproliferative syndrome (ALPS)-like features. Front Pediatr 10: 1014249.","journal-title":"Front Pediatr"},{"key":"ref-1535007","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/cei.13429","article-title":"Vitamin D status and the immune assessment in 22q11.2 deletion syndrome","volume":"200","author":"Legitimo A","year":"2020","unstructured":"Legitimo A, Bertini V, Costagliola G, et al. (2020): Vitamin D status and the immune assessment in 22q11.2 deletion syndrome. Clin Exp Immunol 200: 272-286.","journal-title":"Clin Exp Immunol"},{"key":"ref-1535008","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jaci.2011.06.043","article-title":"Autoimmunity in a cohort of 130 pediatric patients with partial DiGeorge syndrome","volume":"128","author":"Tison BE","year":"2011","unstructured":"Tison BE, Nicholas SK, Abramson SL, et al. (2011): Autoimmunity in a cohort of 130 pediatric patients with partial DiGeorge syndrome. J Allergy Clin Immunol 128: 1115. e1-1117.e3.","journal-title":"J Allergy Clin Immunol"},{"key":"ref-1535009","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1067\/mpd.2001.118534","article-title":"Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome)","volume":"139","author":"Jawad AF","year":"2001","unstructured":"Jawad AF, Mcdonald-Mcginn DM, Zackai E, Sullivan KE (2001): Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome). J Pediatr 139: 715-723.","journal-title":"J Pediatr"},{"key":"ref-1535010","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jpeds.2014.01.056","article-title":"Clinical features and follow-up in patients with 22q11.2 deletion syndrome","volume":"164","author":"Cancrini C","year":"2014","unstructured":"Cancrini C, Puliafito P, Digilio MC, et al. (2014): Clinical features and follow-up in patients with 22q11.2 deletion syndrome. J Pediatr 164: 1475-1480.e1472.","journal-title":"J Pediatr"},{"key":"ref-1535011","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/pai.12420","article-title":"Autoimmunity and regulatory T cells in 22q11.2 deletion syndrome patients","volume":"26","author":"Di Cesare S","year":"2015","unstructured":"Di Cesare S, Puliafito P, Ariganello P, et al. (2015): Autoimmunity and regulatory T cells in 22q11.2 deletion syndrome patients. Pediatr Allergy Immunol 26: 591-594.","journal-title":"Pediatr Allergy Immunol"},{"key":"ref-1535012","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.jaip.2019.03.014","article-title":"Immunophenotype anomalies predict the development of autoimmune cytopenia in 22q11.2 deletion syndrome","volume":"7","author":"Montin D","year":"2019","unstructured":"Montin D, Marolda A, Licciardi F, et al. (2019): Immunophenotype anomalies predict the development of autoimmune cytopenia in 22q11.2 deletion syndrome. J Allergy Clin Immunol Pract 7: 2369-2376.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref-1535013","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/apa.16737","article-title":"Childhood manifestations of 22q11.2 deletion syndrome: A Finnish nationwide register-based cohort study","volume":"112","author":"Wahrmann S","year":"2023","unstructured":"Wahrmann S, Kainulainen L, Kyt\u00f6 V, Lempainen J (2023): Childhood manifestations of 22q11.2 deletion syndrome: A Finnish nationwide register-based cohort study. Acta Paediatr 112: 1312-1318.","journal-title":"Acta Paediatr"},{"key":"ref-1535014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.2007.01949.x","article-title":"Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome","volume":"66","author":"Mclean-Tooke A","year":"2007","unstructured":"Mclean-Tooke A, Spickett GP, Gennery AR (2007): Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome. Scand J Immunol 66: 1-7.","journal-title":"Scand J Immunol"},{"key":"ref-1535015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbi.2018.03.022","article-title":"A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis?","volume":"70","author":"Vergaelen E","year":"2018","unstructured":"Vergaelen E, Schiweck C, Van Steeland K, et al. (2018): A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis? Brain Behav Immun 70: 88-95.","journal-title":"Brain Behav Immun"},{"key":"ref-1535016","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaut.2019.01.011","article-title":"Primary immunodeficiency and autoimmunity: A comprehensive review","volume":"99","author":"Amaya-Uribe L","year":"2019","unstructured":"Amaya-Uribe L, Rojas M, Azizi G, et al. (2019): Primary immunodeficiency and autoimmunity: A comprehensive review. J Autoimmun 99: 52-72.","journal-title":"J Autoimmun"},{"key":"ref-1535017","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1002\/ajmg.a.62346","article-title":"Central 22q11.2 deletion (LCR22 B-D) in a fetus with severe fetal growth restriction and a mother with severe systemic lupus erythematosus: Further evidence of CRKL haploinsufficiency in the pathogenesis of 22q11.2 deletion syndrome","volume":"185","author":"Lin I","year":"2021","unstructured":"Lin I, Afshar Y, Goldstein J, et al. (2021): Central 22q11.2 deletion (LCR22 B-D) in a fetus with severe fetal growth restriction and a mother with severe systemic lupus erythematosus: Further evidence of CRKL haploinsufficiency in the pathogenesis of 22q11.2 deletion syndrome. Am J Med Genet A 185: 3042-3047.","journal-title":"Am J Med Genet A"},{"key":"ref-1535018","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/adc.86.6.422","article-title":"Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome","volume":"86","author":"Gennery AR","year":"2002","unstructured":"Gennery AR, Barge D, O\u2019sullivan JJ, et al. (2002): Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child 86: 422-425.","journal-title":"Arch Dis Child"},{"key":"ref-1535019","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3390\/genes13091552","article-title":"Characterization of autoimmune thyroid disease in a cohort of 73 paediatric patients affected by 22q11.2 deletion syndrome: Longitudinal single-centre study","volume":"13","author":"Ricci S","year":"2022","unstructured":"Ricci S, Sarli WM, Lodi L, et al. (2022): Characterization of autoimmune thyroid disease in a cohort of 73 paediatric patients affected by 22q11.2 deletion syndrome: Longitudinal single-centre study. Genes 13: 1552.","journal-title":"Genes"},{"key":"ref-1535020","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/art.1780400307","article-title":"Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad\/velocardiofacial syndrome\/conotruncal anomaly face syndrome)","volume":"40","author":"Sullivan KE","year":"1997","unstructured":"Sullivan KE, Mcdonald-Mcginn DM, Driscoll DA, et al. (1997): Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad\/velocardiofacial syndrome\/conotruncal anomaly face syndrome). Arthritis Rheum 40: 430-436.","journal-title":"Arthritis Rheum"},{"key":"ref-1535021","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaci.2021.06.007","article-title":"Distinct immune trajectories in patients with chromosome 22q11.2 deletion syndrome and immune-mediated diseases","volume":"149","author":"Crowley TB","year":"2022","unstructured":"Crowley TB, Campbell IM, Liebling EJ, et al. (2022): Distinct immune trajectories in patients with chromosome 22q11.2 deletion syndrome and immune-mediated diseases. J Allergy Clin Immunol 149: 445-450.","journal-title":"J Allergy Clin Immunol"},{"key":"ref-1535022","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10875-020-00854-y","article-title":"Relationship between severity of T cell lymphopenia and immune dysregulation in patients with DiGeorge syndrome (22q11.2 deletions and\/or related TBX1 mutations): a USIDNET study","volume":"41","author":"Deshpande DR","year":"2021","unstructured":"Deshpande DR, Demirdag YY, Marsh RA, et al. (2021): Relationship between severity of T cell lymphopenia and immune dysregulation in patients with DiGeorge syndrome (22q11.2 deletions and\/or related TBX1 mutations): a USIDNET study. J Clin Immunol 41: 29-37.","journal-title":"J Clin Immunol"},{"key":"ref-1535023","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000438708","article-title":"22q11.21 deletion syndromes: A review of proximal, central, and distal deletions and their associated features","volume":"146","author":"Burnside RD","year":"2015","unstructured":"Burnside RD (2015): 22q11.21 deletion syndromes: A review of proximal, central, and distal deletions and their associated features. Cytogenet Genome Res 146: 89-99.","journal-title":"Cytogenet Genome Res"},{"key":"ref-1535024","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00125817-200101000-00005","article-title":"Endocrine aspects of the 22q11.2 deletion syndrome","volume":"3","author":"Weinzimer SA","year":"2001","unstructured":"Weinzimer SA (2001): Endocrine aspects of the 22q11.2 deletion syndrome. Genet Med 3: 19-22.","journal-title":"Genet Med"},{"key":"ref-1535025","doi-asserted-by":"crossref","first-page":"771100","DOI":"10.3389\/fendo.2022.771100","article-title":"Endocrine and growth disorders in Taiwanese children with 22q11.2 deletion syndrome","volume":"13","author":"Lin HY","year":"2022","unstructured":"Lin HY, Tsai WY, Tung YC, et al. (2022): Endocrine and growth disorders in Taiwanese children with 22q11.2 deletion syndrome. Front Endocrinol 13: 771100.","journal-title":"Front Endocrinol"},{"key":"ref-1535026","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jmg.34.10.798","article-title":"Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study","volume":"34","author":"Ryan AK","year":"1997","unstructured":"Ryan AK, Goodship JA, Wilson DI, et al. (1997): Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 34: 798-804.","journal-title":"J Med Genet"},{"key":"ref-1535027","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/gim.2016.98","article-title":"Obesity in adults with 22q11.2 deletion syndrome","volume":"19","author":"Voll SL","year":"2017","unstructured":"Voll SL, Boot E, Butcher NJ, et al. (2017): Obesity in adults with 22q11.2 deletion syndrome. Genet Med 19: 204-208.","journal-title":"Genet Med"},{"key":"ref-1535028","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s40618-023-02276-0","article-title":"Endocrine manifestations in adults with 22q11.2 deletion syndrome: a retrospective single-center cohort study","volume":"47","author":"Soubry E","year":"2024","unstructured":"Soubry E, David K, Swillen A, et al. (2024): Endocrine manifestations in adults with 22q11.2 deletion syndrome: a retrospective single-center cohort study. J Endocrinol Invest 47: 1827-1836.","journal-title":"J Endocrinol Invest"},{"key":"ref-1535029","doi-asserted-by":"crossref","first-page":"100528","DOI":"10.1016\/j.eclinm.2020.100528","article-title":"22q11.2 microdeletion and increased risk for type 2 diabetes","volume":"26","author":"Van L","year":"2020","unstructured":"Van L, Heung T, Malecki SL, et al. (2020): 22q11.2 microdeletion and increased risk for type 2 diabetes. EClinicalMedicine 26: 100528.","journal-title":"EClinicalMedicine"},{"key":"ref-1535030","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41436-019-0645-4","article-title":"Pathogenic variants in CDC45 on the remaining allele in patients with a chromosome 22q11.2 deletion result in a novel autosomal recessive condition","volume":"22","author":"Unolt M","year":"2020","unstructured":"Unolt M, Kammoun M, Nowakowska B, et al. (2020): Pathogenic variants in CDC45 on the remaining allele in patients with a chromosome 22q11.2 deletion result in a novel autosomal recessive condition. Genet Med 22: 326-335.","journal-title":"Genet Med"},{"key":"ref-1535031","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ajmg.a.37980","article-title":"Congenital diaphragmatic hernia in 22q11.2 deletion syndrome","volume":"173","author":"Unolt M","year":"2017","unstructured":"Unolt M, Dicairano L, Schlechtweg K, et al. (2017): Congenital diaphragmatic hernia in 22q11.2 deletion syndrome. Am J Med Genet A 173: 135-142.","journal-title":"Am J Med Genet A"},{"key":"ref-1535032","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/ajmg.a.32378","article-title":"22q11.2 deletion syndrome in patients admitted to a cardiac pediatric intensive care unit in Brazil","volume":"146a","author":"Rosa RF","year":"2008","unstructured":"Rosa RF, Pilla CB, Pereira VL, et al. (2008): 22q11.2 deletion syndrome in patients admitted to a cardiac pediatric intensive care unit in Brazil. Am J Med Genet A 146a: 1655-1661.","journal-title":"Am J Med Genet A"},{"key":"ref-1535033","volume-title":"GeneReviews\u00ae","author":"Mcdonald-Mcginn DM","year":"1993","unstructured":"Mcdonald-Mcginn DM, Hain HS, Emanuel BS, Zackai EH (1993): 22q11.2 deletion syndrome. In: GeneReviews\u00ae. Adam MP, Feldman J, Mirzaa GM, et al. (Eds.). University of Washington. Seattle, WA. NBK1523."},{"key":"ref-1535034","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2466-13-31","article-title":"Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema","volume":"13","author":"Tzouvelekis A","year":"2013","unstructured":"Tzouvelekis A, Zacharis G, Oikonomou A, et al. (2013): Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema. BMC Pulm Med 13: 31.","journal-title":"BMC Pulm Med"},{"key":"ref-1535035","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1017\/S0033291713001669","article-title":"Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated","volume":"44","author":"Tang SX","year":"2014","unstructured":"Tang SX, Yi JJ, Calkins ME, et al. (2014): Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated. Psychol Med 44: 1267-1277.","journal-title":"Psychol Med"},{"key":"ref-1535036","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1176\/appi.ajp.2013.13070864","article-title":"Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 deletion syndrome","volume":"171","author":"Schneider M","year":"2014","unstructured":"Schneider M, Debban\u00e9 M, Bassett AS, et al. (2014): Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 deletion syndrome. Am J Psychiatry 171: 627-639.","journal-title":"Am J Psychiatry"}],"container-title":["Central European Journal of Immunology"],"original-title":[],"link":[{"URL":"https:\/\/ceji.termedia.pl\/pdf-188417-129557","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ceji.termedia.pl\/pdf-188417-129557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:30:36Z","timestamp":1767947436000},"score":1,"resource":{"primary":{"URL":"https:\/\/ceji.termedia.pl\/Systemic-lupus-erythematosus-in-a-patient-with-22q11-2-deletion-syndrome-A-case-report,188417,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"alternative-id":["188417"],"URL":"https:\/\/doi.org\/10.5114\/ceji.2024.143229","relation":{},"ISSN":["1426-3912","1644-4124"],"issn-type":[{"value":"1426-3912","type":"print"},{"value":"1644-4124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]}}}